HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kameshwar Prasad Selected Research

danaparoid (Orgaran)

1/2017Association between Beta-Fibrinogen C148T Gene Polymorphism and Risk of Ischemic Stroke in a North Indian Population: A Case-Control Study.
1/2017Transforming growth factor-β1 (C509T, G800A, and T869C) gene polymorphisms and risk of ischemic stroke in North Indian population: A hospital-based case-control study.
12/2016Association between lymphotoxin alpha (-252 A/G and -804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study.
9/2016Role of Interleukin-10 (-1082A/G) gene polymorphism with the risk of ischemic stroke: a meta-analysis.
7/2016Association between Endothelial nitric oxide synthase G894T gene polymorphism and risk of ischemic stroke in North Indian population: a case-control study.
2/2016Association between Interleukin-10 -1082G/A Gene Polymorphism and Risk of Stroke in the North Indian Population: A Case-Control Study.
1/2016Association between interleukin-6 (G174C and C572G) promoter gene polymorphisms and risk of ischemic stroke in North Indian population: a case-control study.
1/2015Seasonal differences and circadian variation in stroke occurrence and stroke subtypes.
9/2014Risk factors and etiologies of ischemic strokes in young patients: a tertiary hospital study in north India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kameshwar Prasad Research Topics

Disease

40Stroke (Strokes)
06/2022 - 03/2011
33Ischemic Stroke
06/2022 - 06/2008
6Bacterial Meningitis
09/2015 - 03/2004
5Inflammation (Inflammations)
01/2022 - 01/2016
5Hemorrhagic Stroke
07/2021 - 03/2014
5Cerebral Hemorrhage
03/2021 - 09/2016
4COVID-19
05/2022 - 05/2020
4Hearing Loss (Hearing Impairment)
09/2015 - 07/2009
3Epilepsy (Aura)
01/2019 - 12/2011
3Seizures (Absence Seizure)
01/2018 - 06/2007
3Cerebral Infarction
01/2017 - 03/2016
3Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
08/2012 - 03/2004
2Neurologic Manifestations (Neurological Manifestations)
05/2022 - 12/2021
2Respiratory Insufficiency (Respiratory Failure)
12/2021 - 03/2010
2Embolic Stroke
01/2021 - 01/2017
2Dementia (Dementias)
01/2020 - 01/2012
2Hypertension (High Blood Pressure)
01/2018 - 04/2016
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2017 - 03/2016
2Atherosclerosis
12/2016 - 04/2016
2Meningeal Tuberculosis (Tuberculous Meningitis)
04/2016 - 09/2010
2Meningitis
09/2010 - 10/2007
2Status Epilepticus (Complex Partial Status Epilepticus)
05/2008 - 06/2007
1Brain Injuries (Brain Injury)
01/2022
1Fatigue
09/2021
1Papilledema
09/2021
1Tremor (Tremors)
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Thrombosis (Thrombus)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2020
1Headache (Headaches)
12/2020
1Transient Ischemic Attack
10/2020
1Cognitive Dysfunction
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Disorders of Excessive Somnolence (Hypersomnia)
01/2019
1Pulmonary Tuberculosis
01/2019
1Deglutition Disorders (Dysphagia)
01/2018
1Neurocysticercosis
01/2018
1Drug-Related Side Effects and Adverse Reactions
01/2018

Drug/Important Bio-Agent (IBA)

9danaparoid (Orgaran)FDA Link
01/2017 - 09/2014
7CytokinesIBA
01/2017 - 02/2016
6Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2017
6Adrenal Cortex Hormones (Corticosteroids)IBA
04/2016 - 07/2009
5Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2022 - 12/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 08/2012
4Pharmaceutical PreparationsIBA
01/2019 - 06/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
06/2022 - 06/2008
3Glial Fibrillary Acidic ProteinIBA
10/2020 - 01/2017
3Levetiracetam (Keppra)FDA LinkGeneric
01/2019 - 05/2008
3Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2017 - 10/2013
3Interleukin-6 (Interleukin 6)IBA
09/2016 - 04/2015
3Anti-Bacterial Agents (Antibiotics)IBA
08/2012 - 03/2004
2Antihypertensive Agents (Antihypertensives)IBA
02/2022 - 01/2018
2Biological ProductsIBA
01/2022 - 12/2016
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2021 - 09/2014
2Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 01/2012
2VaccinesIBA
01/2021 - 10/2007
2Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2017
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2020 - 09/2018
2Nitroglycerin (Dynamite)FDA LinkGeneric
01/2018 - 01/2018
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
08/2017 - 10/2013
2factor V LeidenIBA
07/2017 - 10/2013
2Transforming Growth Factor beta (TGF-beta)IBA
01/2017 - 04/2016
2Fibrinogen (Factor I)FDA Link
01/2017 - 10/2013
2Lymphotoxin-alpha (Lymphotoxin)IBA
12/2016 - 03/2016
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2016 - 01/2011
2Interleukin-10 (Interleukin 10)IBA
09/2016 - 02/2016
2beta-2 Adrenergic ReceptorsIBA
06/2014 - 03/2014
2Apolipoproteins E (ApoE)IBA
10/2013 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
07/2012 - 03/2011
1ORALIT (ORS)IBA
12/2021
1Retinaldehyde (Retinal)IBA
09/2021
1ChAdOx1 nCoV-19IBA
01/2021
1Adenovirus VaccinesIBA
01/2021
1Botulinum Toxins (Botulinum Toxin)IBA
01/2021
1Proteinase-Activated ReceptorsIBA
12/2020
1Endothelial Protein C ReceptorIBA
12/2020
1Poly (ADP-Ribose) Polymerase-1IBA
12/2020
1activated protein C receptorIBA
12/2020
1Analgesics (Analgesic Drugs)IBA
12/2020
1fibrin fragment D (D-dimer)IBA
10/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
10/2020
1Cystatin CIBA
01/2020
1TenecteplaseFDA Link
09/2019
1Oxcarbazepine (Trileptal)FDA LinkGeneric
01/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2018
1Clopidogrel (Plavix)FDA Link
12/2018
1Matrix Metalloproteinases (MMPs)IBA
09/2018
1Matrix Metalloproteinase 3 (Stromelysin 1)IBA
09/2018
1Factor V (Coagulation Factor V)IBA
07/2017

Therapy/Procedure

18Therapeutics
02/2022 - 03/2004
3Length of Stay
05/2022 - 03/2016
3Artificial Respiration (Mechanical Ventilation)
03/2016 - 03/2012
2Transplantation
12/2017 - 04/2014
1Thrombectomy
06/2022
1Cannula
12/2021
1Injections
01/2021
1Activities of Daily Living (ADL)
03/2018
1Ambulatory Care (Outpatient Care)
12/2017